1. Home
  2. MBX
  3. MBX News

Latest MBX BIOSCIENCES INC (MBX) News on July 1, 2025

MBX Biosciences Appoints Andreas Moraitis, M.D., as Senior Vice President of Clinical Development
MBX

GlobeNewswire

8 days ago

MBX Biosciences Appoints Andreas Moraitis, M.D., as Senior Vice President of Clinical Development

MBX Biosciences Announces IND Submission of MBX 4291, its Long-acting GLP1/GIP Receptor Co-agonist Prodrug for the Treatment of Obesity
MBX

GlobeNewswire

15 days ago

MBX Biosciences Announces IND Submission of MBX 4291, its Long-acting GLP1/GIP Receptor Co-agonist Prodrug for the Treatment of Obesity

MBX Biosciences to Present at the American Diabetes Association 85th Scientific Sessions
MBX

GlobeNewswire

21 days ago

MBX Biosciences to Present at the American Diabetes Association 85th Scientific Sessions

MBX Biosciences to Participate in June Investor Conferences
MBX

GlobeNewswire

a month ago

MBX Biosciences to Participate in June Investor Conferences

MBX Biosciences Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
MBX

GlobeNewswire

2 months ago

MBX Biosciences Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Companies Like MBX Biosciences (NASDAQ:MBX) Are In A Position To Invest In Growth
MBX

Simply Wall St.

2 months ago

Companies Like MBX Biosciences (NASDAQ:MBX) Are In A Position To Invest In Growth

MBX Biosciences to Participate in Citizens and RBC May Investor Conferences
MBX

GlobeNewswire

2 months ago

MBX Biosciences to Participate in Citizens and RBC May Investor Conferences

MBX Biosciences Appoints Veteran Pharmaceutical Executive Steve Hoerter to Board of Directors
MBX

GlobeNewswire

3 months ago

MBX Biosciences Appoints Veteran Pharmaceutical Executive Steve Hoerter to Board of Directors

MBX Biosciences to Participate in the 24th Annual Needham Virtual Healthcare Conference
MBX

GlobeNewswire

3 months ago

MBX Biosciences to Participate in the 24th Annual Needham Virtual Healthcare Conference

MBX Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights
MBX

GlobeNewswire

3 months ago

MBX Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights

Insider Buyers At MBX Biosciences Likely Disappointed With 17% Slide
MBX

Simply Wall St.

4 months ago

Insider Buyers At MBX Biosciences Likely Disappointed With 17% Slide

MBX

MT Newswires

4 months ago

Top Premarket Decliners

MBX Biosciences Announces Additions to Leadership Team
MBX

GlobeNewswire

4 months ago

MBX Biosciences Announces Additions to Leadership Team

MBX Biosciences Completes Enrollment in Phase 2 Avail™ Trial of MBX 2109 (Canvuparatide) for Hypoparathyroidism
MBX

GlobeNewswire

4 months ago

MBX Biosciences Completes Enrollment in Phase 2 Avail™ Trial of MBX 2109 (Canvuparatide) for Hypoparathyroidism

MBX Biosciences to Participate in March Investor Conferences
MBX

GlobeNewswire

4 months ago

MBX Biosciences to Participate in March Investor Conferences

MBX Biosciences to Participate in Upcoming February Investor Conferences
MBX

GlobeNewswire

5 months ago

MBX Biosciences to Participate in Upcoming February Investor Conferences

MBX Biosciences' Investigational Drug For Weight Loss Surgery-Related Low Blood Sugar Shows Encouraging Action
MBX

Benzinga

6 months ago

MBX Biosciences' Investigational Drug For Weight Loss Surgery-Related Low Blood Sugar Shows Encouraging Action

MBX Biosciences Announces Positive Phase 1 Topline Results for MBX 1416 for the Treatment of Post-bariatric Hypoglycemia
MBX

GlobeNewswire

6 months ago

MBX Biosciences Announces Positive Phase 1 Topline Results for MBX 1416 for the Treatment of Post-bariatric Hypoglycemia

MBX Biosciences to Participate in 43rd Annual J.P. Morgan Healthcare Conference
MBX

GlobeNewswire

6 months ago

MBX Biosciences to Participate in 43rd Annual J.P. Morgan Healthcare Conference

MBX Biosciences Announces MBX 2109 Phase 1 Study Results Published in The Journal of Clinical Endocrinology and Metabolism
MBX

GlobeNewswire

7 months ago

MBX Biosciences Announces MBX 2109 Phase 1 Study Results Published in The Journal of Clinical Endocrinology and Metabolism

MBX Biosciences Announces Last Subject Last Visit in Phase 1 Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia
MBX

GlobeNewswire

7 months ago

MBX Biosciences Announces Last Subject Last Visit in Phase 1 Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia

MBX Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update
MBX

GlobeNewswire

8 months ago

MBX Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update

MBX Biosciences to Participate in Upcoming November Investor Conferences
MBX

GlobeNewswire

8 months ago

MBX Biosciences to Participate in Upcoming November Investor Conferences

Opening Day: Another trio of biotech IPOs make Friday debut
MBX

TipRanks

9 months ago

Opening Day: Another trio of biotech IPOs make Friday debut

MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting
MBX

GlobeNewswire

9 months ago

MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting

MBX

GuruFocus.com

9 months ago

Deep Track Capital, LP's Strategic Acquisition in MBX Biosciences Inc

MBX

GuruFocus.com

9 months ago

OrbiMed Advisors LLC Acquires New Stake in MBX Biosciences Inc

MBX Biosciences Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
MBX

GlobeNewswire

9 months ago

MBX Biosciences Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Share on Social Networks: